510(k) · Cleared
ClearedCeevra Reveal 3+
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ceevra, Inc. · QIH Automated Radiological Image Processing Software
Cleared on Dec 5, 2023 as substantially equivalent to K222676 (Ceevra, Inc., 2023) after a 29-day review. Its family tree reaches back 11 generations to 1993. 2 later devices descend from it.
- Decided
- Dec 5, 2023
- Review
- 29 days
- Class
- Class II
- Product code
- QIH
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 11 generations to K924630 (1993). 13 ancestors in all, the oldest K924810 (1993). 2 later devices descend from it, 1 citing it directly.
- Root · 11 generations backK924630 Surgicad (TM) View (TM)Surgicad Corp. · 1993
- 7 generations between
- 3 generations backK171356 Clarity RevealCeevra, Inc. · 2017
- 2 generations backK173274 Ceevra Reveal 2.0Ceevra, Inc. · 2018
- 1 generation backK222676 Ceevra Reveal 3Ceevra, Inc. · 2023
- This deviceK233568 Ceevra Reveal 3+Ceevra, Inc. · 2023
- Descendant · cites it directly · 1 of its ownK243933 Ceevra Reveal 3+Ceevra, Inc. · 2025
- Descendant · 2 generations on · 0 of its ownK261595 Ceevra Reveal 4Ceevra, Inc. · 2026
Show all 11 generations
- Root · 11 generations backK924630 Surgicad (TM) View (TM)Surgicad Corp. · 1993
- 10 generations backK970617 CT-Modeller SystemMaterialise NV · 1997
- 9 generations backK033849 Simplant SystemMaterialise NV · 2004
- 8 generations backK073468 MimicsMaterialise NV · 2008
- 7 generations backK093269 Procedure Rehearsal StudioSimbionix, Ltd. · 2010
- 6 generations backK112387 Procedure Rehearsal Studio (TM)Simbionix, Ltd. · 2011
- 5 generations backK123023 Surgery Rehearsal PlatformSurgical Theater, LLC · 2013
- 4 generations backK142107 Echo True 3D ViewerEchopixel, Inc. · 2015 · Recalled
- 3 generations backK171356 Clarity RevealCeevra, Inc. · 2017
- 2 generations backK173274 Ceevra Reveal 2.0Ceevra, Inc. · 2018
- 1 generation backK222676 Ceevra Reveal 3Ceevra, Inc. · 2023
- This deviceK233568 Ceevra Reveal 3+Ceevra, Inc. · 2023
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −11 | K924630 | Surgicad (TM) View (TM) | Surgicad Corp. | 1993 | — |
| −10 | K970617 | CT-Modeller System | Materialise NV | 1997 | — |
| −9 | K033849 | Simplant System | Materialise NV | 2004 | — |
| −8 | K073468 | Mimics | Materialise NV | 2008 | — |
| −7 | K093269 | Procedure Rehearsal Studio | Simbionix, Ltd. | 2010 | — |
| −6 | K112387 | Procedure Rehearsal Studio (TM) | Simbionix, Ltd. | 2011 | — |
| −5 | K123023 | Surgery Rehearsal Platform | Surgical Theater, LLC | 2013 | — |
| −4 | K142107 | Echo True 3D Viewer | Echopixel, Inc. | 2015 | 1 |
| −3 | K171356 | Clarity Reveal | Ceevra, Inc. | 2017 | — |
| −2 | K173274 | Ceevra Reveal 2.0 | Ceevra, Inc. | 2018 | — |
| −1 | K222676 | Ceevra Reveal 3 | Ceevra, Inc. | 2023 | — |
| 0 (this device) | K233568 | Ceevra Reveal 3+ | Ceevra, Inc. | 2023 | — |
| +1 | K243933 | Ceevra Reveal 3+ | Ceevra, Inc. | 2025 | — |
| +2 | K261595 | Ceevra Reveal 4 | Ceevra, Inc. | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1993 | 1 | 0 |
| 2007 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in QIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new QIH device
- #1 K213998 cvi42 Auto Imaging Software Applicationscore 23.5 · 7 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K222676 | Ceevra Reveal 3Summary page 4…II 3. Originally Cleared Device Proprietary Name Ceevra Reveal 3 Common Name Reveal 3 Premarket Notification K222676 Classification Name Automated Radiological Image Processing Software Regulation Number 21 CFR 892… | 2023 |
What descends from it? (2)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K243933 | Ceevra Reveal 3+ | 2025 | 1 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 30 years and passes through 6 companies; a new generation was cleared every 2.4 years on median.
- 1 of the 13 ancestors has a recall of any class.
- Of its descendants, K243933 (Ceevra, Inc., 2025) has gone furthest, with 1 descendant of its own.
- 2 other devices also cite its predicate K222676.
How does its category compare?
All QIH devicesQIH Automated Radiological Image Processing Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · QIH
94in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · QIH
150in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · QIH
1so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · QIH
4in 2025
MAUDE reports naming product code QIH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 0 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 11 | 145 | 0 | 0 |
| 2021 | 19 | 125 | 0 | 0 |
| 2022 | 25 | 134 | 0 | 0 |
| 2023 | 45 | 151 | 0 | 0 |
| 2024 | 64 | 141 | 0 | 2 |
| 2025 | 94 | 150 | 0 | 4 |
| 2026 | 78 | 130 | 1 | — |
What is it indicated for?
Ceevra Reveal 3+ is intended as a medical imaging system that allows the processing, review, analysis, communication and media interchange of multi-dimensional digital images acquired from CT or MR imaging devices and that such processing may include the generation of preliminary segmentations of normal anatomy using software that employs machine learning and other computer vision algorithms. It is also intended as software for preoperative surgical…
Read the full statement (151 words)
Ceevra Reveal 3+ is intended as a medical imaging system that allows the processing, review, analysis, communication and media interchange of multi-dimensional digital images acquired from CT or MR imaging devices and that such processing may include the generation of preliminary segmentations of normal anatomy using software that employs machine learning and other computer vision algorithms. It is also intended as software for preoperative surgical planning, and as software for the intraoperative display of the aforementioned multi-dimensional digital images.
Ceevra Reveal 3+ is designed for use by health care professionals and is intended to assist the clinician who is responsible for making all final patient management decisions.
The machine learning algorithms in use by Ceevra Reveal 3+ are for use only for adult patients (22 and over). Three-dimensional images for patients under the age of 22 or of unknown age will be generated without the use of any machine learning algorithms.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K233568 · printed Nov 5, 2026
Cite this page
510(k) Report. “K233568: Ceevra Reveal 3+.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K233568
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026